185 related articles for article (PubMed ID: 27999042)
1. Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam.
Sousa Dominguez A; Perez-Rodríguez MT; Nodar A; Martinez-Lamas L; Perez-Landeiro A; Crespo Casal M
J Antimicrob Chemother; 2017 Apr; 72(4):1262-1263. PubMed ID: 27999042
[No Abstract] [Full Text] [Related]
2. Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes.
Dietl B; Sánchez I; Arcenillas P; Cuchi E; Gómez L; González de Molina FJ; Boix-Palop L; Nicolás J; Calbo E
Int J Antimicrob Agents; 2018 Mar; 51(3):498-502. PubMed ID: 29158144
[TBL] [Abstract][Full Text] [Related]
3. Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam.
Castaldo N; Givone F; Peghin M; Righi E; Sartor A; Bassetti M
J Glob Antimicrob Resist; 2017 Jun; 9():100-102. PubMed ID: 28495526
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in Germany.
Seifert H; Körber-Irrgang B; Kresken M;
Int J Antimicrob Agents; 2018 Feb; 51(2):227-234. PubMed ID: 28705666
[TBL] [Abstract][Full Text] [Related]
5. Postoperative soft-tissue infection due to multidrug-resistant Pseudomonas aeruginosa: usefulness of ceftolozane-tazobactam.
Monterrubio-Villar J; Rodríguez-Garrido S; Jiménez-Delgado JD
Rev Esp Quimioter; 2018 Aug; 31(4):374-375. PubMed ID: 30014680
[No Abstract] [Full Text] [Related]
6. Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam.
Hernández-Tejedor A; Merino-Vega CD; Martín-Vivas A; Ruiz de Luna-González R; Delgado-Iribarren A; Gabán-Díez Á; Temprano-Gómez I; de la Calle-Pedrosa N; González-Jiménez AI; Algora-Weber A
Infection; 2017 Feb; 45(1):115-117. PubMed ID: 27670678
[TBL] [Abstract][Full Text] [Related]
7. Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipients.
Hakki M; Lewis JS
Infection; 2018 Jun; 46(3):431-434. PubMed ID: 29460229
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of three severe MDR or XDR Pseudomonas aeruginosa infections with ceftolozane/tazobactam.
Xipell M; Bodro M; Marco F; Martínez JA; Soriano A
Future Microbiol; 2017 Nov; 12():1323-1326. PubMed ID: 28980834
[TBL] [Abstract][Full Text] [Related]
9. Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance.
Haidar G; Philips NJ; Shields RK; Snyder D; Cheng S; Potoski BA; Doi Y; Hao B; Press EG; Cooper VS; Clancy CJ; Nguyen MH
Clin Infect Dis; 2017 Jul; 65(1):110-120. PubMed ID: 29017262
[TBL] [Abstract][Full Text] [Related]
10. Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa.
Gelfand MS; Cleveland KO
Clin Infect Dis; 2015 Sep; 61(5):853-5. PubMed ID: 26021991
[No Abstract] [Full Text] [Related]
11. Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience.
Buonomo AR; Maraolo AE; Scotto R; Foggia M; Zappulo E; Congera P; Parente S; Gentile I
Infection; 2020 Apr; 48(2):303-307. PubMed ID: 31981091
[TBL] [Abstract][Full Text] [Related]
12. Ceftolozane/tazobactam sensitivity patterns in Pseudomonas aeruginosa isolates recovered from sputum of cystic fibrosis patients.
Finklea JD; Hollaway R; Lowe K; Lee F; Le J; Jain R
Diagn Microbiol Infect Dis; 2018 Sep; 92(1):75-77. PubMed ID: 29884565
[TBL] [Abstract][Full Text] [Related]
13. Treatment of multidrug-resistant Pseudomonas aeruginosa with ceftolozane/tazobactam in a critically ill patient receiving continuous venovenous haemodiafiltration.
Kuti JL; Ghazi IM; Quintiliani R; Shore E; Nicolau DP
Int J Antimicrob Agents; 2016 Sep; 48(3):342-3. PubMed ID: 27451086
[No Abstract] [Full Text] [Related]
14. Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant.
Peghin M; Maiani M; Castaldo N; Givone F; Righi E; Lechiancole A; Sartor A; Pea F; Livi U; Bassetti M
Infection; 2018 Apr; 46(2):263-265. PubMed ID: 29086895
[TBL] [Abstract][Full Text] [Related]
15. Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections.
Castón JJ; De la Torre Á; Ruiz-Camps I; Sorlí ML; Torres V; Torre-Cisneros J
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956431
[TBL] [Abstract][Full Text] [Related]
16. Emergence of Ceftolozane-Tazobactam-Resistant Pseudomonas aeruginosa during Treatment Is Mediated by a Single AmpC Structural Mutation.
MacVane SH; Pandey R; Steed LL; Kreiswirth BN; Chen L
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947473
[TBL] [Abstract][Full Text] [Related]
17. Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa.
Munita JM; Aitken SL; Miller WR; Perez F; Rosa R; Shimose LA; Lichtenberger PN; Abbo LM; Jain R; Nigo M; Wanger A; Araos R; Tran TT; Adachi J; Rakita R; Shelburne S; Bonomo RA; Arias CA
Clin Infect Dis; 2017 Jul; 65(1):158-161. PubMed ID: 28329350
[TBL] [Abstract][Full Text] [Related]
18. Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa.
Vickery SB; McClain D; Wargo KA
Pharmacotherapy; 2016 Oct; 36(10):e154-e159. PubMed ID: 27522066
[TBL] [Abstract][Full Text] [Related]
19. Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a Pediatric Leukemia Patient.
Aitken SL; Kontoyiannis DP; DePombo AM; Bhatti MM; Tverdek FP; Gettys SC; Nicolau DP; Nunez CA
Pediatr Infect Dis J; 2016 Sep; 35(9):1040-2. PubMed ID: 27254038
[TBL] [Abstract][Full Text] [Related]
20. Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa.
Álvarez Lerma F; Muñoz Bermudez R; Grau S; Gracia Arnillas MP; Sorli L; Recasens L; Mico García M
Rev Esp Quimioter; 2017 Jun; 30(3):224-228. PubMed ID: 28361526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
